The hemocue albumin 201 system is designed to be used for the quantitative determination of low levels of albumin in urine at the point-of-care for the purpose of screening for, diagnosing, monitoring and to supplement the clinical evidence in the treatment of microalbuminuria. Hemocue’s patented microcuvette technology enables quantitative test results right at the point-of-care. So you can make immediate treatment decisions, rather than waiting for a lab to confirm semi-quantitative tests. FeaturesClia waivedLab accurateResults within 90 secondsOnly clia-waived device for diagnosing and monitoring albuminuria at the point-of-care2 Vials Per BoxSpecificationsWeight: 0.2 lbs
Trustpilot
2 weeks ago
1 week ago
